T. Soysal Et Al. , "THE EFFICACY AND SAFETY OF GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER SWITCHING FROM GLIVEC: UPDATED DATA FROM CERRAHPASA CML COHORT," 20th Congress of European-Hematology-Association , vol.100, Vienna, Austria, pp.447, 2015
Soysal, T. Et Al. 2015. THE EFFICACY AND SAFETY OF GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER SWITCHING FROM GLIVEC: UPDATED DATA FROM CERRAHPASA CML COHORT. 20th Congress of European-Hematology-Association , (Vienna, Austria), 447.
Soysal, T., Eskazan, A. E., Sadri, S., Erdogan, I., Berk, S., Yalniz, F. F., ... Elverdi, T.(2015). THE EFFICACY AND SAFETY OF GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER SWITCHING FROM GLIVEC: UPDATED DATA FROM CERRAHPASA CML COHORT . 20th Congress of European-Hematology-Association (pp.447). Vienna, Austria
Soysal, T. Et Al. "THE EFFICACY AND SAFETY OF GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER SWITCHING FROM GLIVEC: UPDATED DATA FROM CERRAHPASA CML COHORT," 20th Congress of European-Hematology-Association, Vienna, Austria, 2015
Soysal, T. Et Al. "THE EFFICACY AND SAFETY OF GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER SWITCHING FROM GLIVEC: UPDATED DATA FROM CERRAHPASA CML COHORT." 20th Congress of European-Hematology-Association , Vienna, Austria, pp.447, 2015
Soysal, T. Et Al. (2015) . "THE EFFICACY AND SAFETY OF GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER SWITCHING FROM GLIVEC: UPDATED DATA FROM CERRAHPASA CML COHORT." 20th Congress of European-Hematology-Association , Vienna, Austria, p.447.
@conferencepaper{conferencepaper, author={T. Soysal Et Al. }, title={THE EFFICACY AND SAFETY OF GENERIC IMATINIB IN PATIENTS WITH CHRONIC MYELOID LEUKEMIA (CML) AFTER SWITCHING FROM GLIVEC: UPDATED DATA FROM CERRAHPASA CML COHORT}, congress name={20th Congress of European-Hematology-Association}, city={Vienna}, country={Austria}, year={2015}, pages={447} }